Negative regulation of c-myc transcription involves myc family proteins. 1988

J L Cleveland, and M Huleihel, and P Bressler, and U Siebenlist, and L Akiyama, and R N Eisenman, and U R Rapp
Laboratory of Viral Carcinogenesis, National Cancer Institute, FCRF, Frederick, Maryland 21701.

Expression of the c-myc gene is suppressed in NIH 3T3 mouse fibroblast cells infected with recombinant retroviruses expressing high levels of v-myc (10-fold greater than those of c-myc). Suppression of steady state levels of c-myc mRNA occurred at least in part at the level of transcription from c-myc promoters P1 and P2, and involved v-myc protein since cells infected with constructs containing frameshifts and deletions in v-myc had normal levels of c-myc mRNA and protein. Suppression of c-myc expression was also observed in fibroblasts transfected with a N-myc expression vector and in fibroblasts infected with a c-myc retrovirus. These findings establish that v-myc protein is involved either directly or indirectly in a regulatory circuit which represses c-myc proto-oncogene transcription. Feedback regulation of c-myc transcription may be relevant in establishing the lineage specific expression of myc family proto-oncogenes. Reduced steady state levels of c-myc mRNA were also observed in NIH 3T3 cells infected with 12S and 13S EIA recombinant retroviruses suggesting that the exogenous oncogene of adenovirus, EIA, can alleviate the requirement of myc for cell growth and may also share transcriptional target genes.

UI MeSH Term Description Entries
D009856 Oncogene Proteins, Viral Products of viral oncogenes, most commonly retroviral oncogenes. They usually have transforming and often protein kinase activities. Viral Oncogene Proteins,Viral Transforming Proteins,v-onc Proteins,Transforming Proteins, Viral,v onc Proteins
D009857 Oncogenes Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of "v-" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix "c-" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene. Transforming Genes,Oncogene,Transforming Gene,Gene, Transforming,Genes, Transforming
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription

Related Publications

J L Cleveland, and M Huleihel, and P Bressler, and U Siebenlist, and L Akiyama, and R N Eisenman, and U R Rapp
January 1997, Current topics in microbiology and immunology,
J L Cleveland, and M Huleihel, and P Bressler, and U Siebenlist, and L Akiyama, and R N Eisenman, and U R Rapp
April 1990, The EMBO journal,
J L Cleveland, and M Huleihel, and P Bressler, and U Siebenlist, and L Akiyama, and R N Eisenman, and U R Rapp
May 2007, Endocrinology,
J L Cleveland, and M Huleihel, and P Bressler, and U Siebenlist, and L Akiyama, and R N Eisenman, and U R Rapp
June 2012, Proceedings of the National Academy of Sciences of the United States of America,
J L Cleveland, and M Huleihel, and P Bressler, and U Siebenlist, and L Akiyama, and R N Eisenman, and U R Rapp
March 2012, Cell cycle (Georgetown, Tex.),
J L Cleveland, and M Huleihel, and P Bressler, and U Siebenlist, and L Akiyama, and R N Eisenman, and U R Rapp
January 1992, Critical reviews in oncogenesis,
J L Cleveland, and M Huleihel, and P Bressler, and U Siebenlist, and L Akiyama, and R N Eisenman, and U R Rapp
January 1997, Molecular and cellular biology,
J L Cleveland, and M Huleihel, and P Bressler, and U Siebenlist, and L Akiyama, and R N Eisenman, and U R Rapp
January 1988, Current topics in microbiology and immunology,
J L Cleveland, and M Huleihel, and P Bressler, and U Siebenlist, and L Akiyama, and R N Eisenman, and U R Rapp
June 2014, The Journal of biological chemistry,
J L Cleveland, and M Huleihel, and P Bressler, and U Siebenlist, and L Akiyama, and R N Eisenman, and U R Rapp
January 2003, The Journal of biological chemistry,
Copied contents to your clipboard!